Danny Mays, PA
Medical · Santa Fe, NMNPI 1740201672
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 200 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,289 and has fallen 53.4% since, to $600 in 2025. Among medical clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$713
- Novo Nordisk$352
- Boehringer Ingelheim$297
- Johnson & Johnson$259
- AbbVie$253
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$245
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,152100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $713 |
| Novo Nordisk | 20 | $352 |
| Boehringer Ingelheim | 15 | $297 |
| Johnson & Johnson | 12 | $259 |
| AbbVie | 13 | $253 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $245 |
| Lilly USA, LLC | 9 | $230 |
| E.r. Squibb & Sons, L.L.C. | 6 | $211 |
| Daiichi Sankyo Inc. | 12 | $188 |
| Pfizer | 7 | $121 |
| Sanofi-aventis U.S. LLC | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Amgen | 5 | $93 |
| Nestle Healthcare Nutrition Inc. | 5 | $93 |
| Mylan Specialty L.p. | 4 | $88 |
| GSK | 5 | $84 |
| Novartis | 3 | $66 |
| Bayer | 4 | $66 |
| Grifols USA, LLC | 3 | $64 |
| Merck | 4 | $59 |
| Viatris Specialty LLC | 2 | $58 |
| Abbott | 3 | $51 |
| Baxter Healthcare | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Exact Sciences | 2 | $29 |
| Neurocrine Biosciences, Inc. | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Bioventus LLC | 1 | $20 |
| Vertex | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Kerecis Limited | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,158 in reported general payments places this provider in the 90th percentile of 156 medical providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $89,158 |
| EliquisApixaban | 74 | $86,148 |
| XareltoRivaroxaban | 30 | $39,068 |
| TrulicityDulaglutide | 30 | $36,072 |
| Nurtec OdtRimegepant Sulfate | 19 | $30,048 |
| RexultiBrexpiprazole | 17 | $26,228 |
| FarxigaDapagliflozin Propanediol | 25 | $22,998 |
| MounjaroTirzepatide | 19 | $22,193 |
| MyrbetriqMirabegron | 34 | $16,831 |
| JanuviaSitagliptin Phosphate | 16 | $15,487 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $14,315 |
| BelsomraSuvorexant | 25 | $11,794 |
| JardianceEmpagliflozin | 12 | $9,590 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $8,041 |
| Buprenorphine | 13 | $6,810 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt | $121 | $116,19693 claims |
| Novo NordiskOzempic | $352 | $89,15880 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $230 | $58,26549 claims |
| Johnson & JohnsonXarelto | $259 | $39,06830 claims |
| MerckJanuvia, Belsomra, Janumet | $59 | $33,97353 claims |
| AstraZenecaFarxiga, Symbicort | $713 | $31,03947 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $99 | $26,22817 claims |
| GSKTrelegy Ellipta | $84 | $14,31522 claims |
| Boehringer IngelheimJardiance | $297 | $9,59012 claims |
| AbbVieSynthroid | $253 | $1,63251 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 156 medical providers in New Mexico.
Other medical in Santa Fe
- William BaconSanta Fe$6K
- Brenda PachecoAcoma$12K
- Paul TapiaAlbuquerque$7K
- Niki NinopoulosAlbuquerque$7K
- Katie JoshiAlbuquerque$6K
- Loretta GonzalesAlbuquerque$5K
- Sarah East BrumanaRoswell$5K
- Ruben FrancoAlbuquerque$4K
- Bradford GwytherAlbuquerque$4K
- Chelsie WordAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.